SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is seeing massive volatility after the FDA released briefing documents questioning the effectiveness of deramiocel for Duchenne muscular dystrophy ahead of the July 29 advisory committee. The community is sharply divided, with bulls pointing to potential statistical misunderstandings between the company and regulators, while skeptics warn that the negative regulatory language signals a high risk of rejection.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is facing increased volatility and intense community debate following an arbitration ruling that dismissed their claims against 3D Medicines. Despite this legal setback, many investors remain focused on the long-anticipated 80th survival event and topline data from the Phase 3 REGAL trial, with bulls maintaining that the licensing agreement remains intact and the core clinical thesis is unchanged.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is facing a significant sell-off as investors scrutinize the company's circular financing arrangements with key AI partners and increased debt concerns, while community sentiment remains sharply divided between those calling for a structural bubble pop and those viewing the dip as a high-conviction buying opportunity.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

The SPDR Dow Jones Industrial Average ETF (DIA) is currently at the center of market volatility as investors weigh escalating geopolitical tensions in the Middle East against high-stakes AI-driven tech earnings and shifting Federal Reserve rate expectations. The community is actively debating the sustainability of current market valuations, with many traders discussing potential hedging strategies and rotating capital in response to conflicting signals from macro economic data and war-related headlines.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BitMine Immersion Technologies is trending following a strategic shift to prioritize share buybacks over rapid Ethereum accumulation, a move aimed at reducing the float and addressing the discount to net asset value. While management highlights these buybacks as a shareholder-friendly initiative, the community remains deeply divided, with some investors focusing on long-term accumulation potential and crypto-tokenization tailwinds, while others express frustration over share dilution and previous performance headwinds.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum Inc. is seeing intense community focus following the announcement that AT&T is expanding its use of D-Wave's quantum technology to optimize complex network operations, a move that reduced processing times significantly. Investors and analysts are actively debating the company's valuation multiples and the broader long-term potential of the quantum sector, especially as the stock navigates recent volatility and transitions its listing to the Nasdaq.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending as investors grapple with heightened geopolitical volatility in the Middle East, specifically reports of disrupted tanker traffic in the Strait of Hormuz and escalating conflict. Community discussion is heavily focused on the potential for sustained supply shocks, the impact of the current administration's military posture on oil prices, and intense speculation regarding the underlying manipulation of crude oil markets.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

ProShares Ultra Bloomberg Crude Oil is experiencing significant volatility as the market reacts to shifting geopolitical tensions between the U.S. and Iran, alongside fluctuating reports on the potential for a ceasefire and the status of the Strait of Hormuz. Community members are actively debating the sustainability of oil prices, with many traders closely monitoring energy inventory data and supply chain disruptions while expressing polarized views on whether the current market environment favors a bullish or bearish outlook.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is experiencing high volatility as traders react to shifting developments in Middle East geopolitical tensions and ongoing market speculation regarding potential Federal Reserve interest rate adjustments. The community remains deeply divided, with many actively debating the validity of "pump and dump" signals from political figures while others look for support levels and tactical opportunities amid heavy short-selling pressure.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is capturing market attention following the announcement of executive orders aimed at accelerating U.S. quantum technology, with community discourse divided between optimism over federal funding support and skepticism regarding the company's path to profitability. While some investors are bullish on its long-term potential and government-linked partnerships, others remain concerned about high cash burn rates and valuation volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cancer Stocks That Are Advancing the Future of Oncology Care

Oncology innovation is accelerating as AI, immunotherapy and targeted drugs drive growth for cancer-focused biotech and pharma stocks.

Xilio Therapeutics, Inc. (XLO) Reports Q1 Loss, Beats Revenue Estimates

Xilio Therapeutics (XLO) delivered earnings and revenue surprises of +12.12% and +48.45%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Opus Genetics, Inc. (IRD) Reports Q1 Loss, Misses Revenue Estimates

Opus Genetics, Inc. (IRD) delivered earnings and revenue surprises of -374.68% and -23.18%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Oculis Holding AG (OCS) Reports Q1 Loss, Lags Revenue Estimates

Oculis Holding AG (OCS) delivered earnings and revenue surprises of -27.71% and -17.08%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Xilio Therapeutics (XLO) Upgraded to Buy: What Does It Mean for the Stock?

Xilio Therapeutics (XLO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Wall Street Zen Upgrades Xilio Therapeutics (NASDAQ:XLO) to Buy

Wall Street Zen raised Xilio Therapeutics from a "hold" rating to a "buy" rating in a research report on Saturday...

Cancer Stocks to Buy as Innovation Reshapes Global Oncology Market

Oncology is evolving fast as immunotherapy, AI and targeted drugs expand treatment options, boost outcomes, and fuel long-term healthcare growth.

Xilio Therapeutics (NASDAQ:XLO) Shares Down 4.8% - What's Next?

Xilio Therapeutics (NASDAQ:XLO) Stock Price Down 4.8% - What's Next...

Xilio Therapeutics (NASDAQ:XLO) Sees Unusually-High Trading Volume - Here's What Happened

Xilio Therapeutics (NASDAQ:XLO) Sees Strong Trading Volume - Here's Why...

Xilio Therapeutics, Inc. (XLO) Reports Q3 Loss, Misses Revenue Estimates

Xilio Therapeutics (XLO) delivered earnings and revenue surprises of 0.00% and -28.51%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of tumor-activated immuno-oncology therapies for the treatment of cancer. The firm uses its Geographically Precise Solutions (GPS) platform to develop tumor-activated molecules, including cytokines, antibodies and other biologics. The company was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.

Xilio Therapeutics Inc

Xilio Stock Jumps 8% On Cancer Drug Data; Gilead Boost Extends Cash Runway Into 2027 — Retail Says Stock Undervalued

Equity

Neutral Sentiment

Above 2%

1% to 2%

Below 1%

Negative growth

The Q2 2026 GDP advance estimate lands Thursday, July 30, with the Atlanta Fed's GDPNow model nowcasting just 1.7% annualized growth, a sharp step-down from the roughly 3% pace it projected earlier in the quarter. Where do you think GDP comes in? Vote and explain your reasoning in the comments.

The Q2 GDP advance estimate releases Thursday. Atlanta Fed&#39;s GDPNow model is pointing to just 1.7% growth, down sharply from its ~3% nowcast earlier this quarter. Where do you think GDP comes in?

Stocktwits

The Q2 GDP advance estimate releases Thursday. Atlanta Fed's GDPNow model is pointing to just 1.7% growth, down sharply from its ~3% nowcast earlier this quarter. Where do you think GDP comes in?

Feed

News

Sentiment

Fundamentals

Info

XLOXilio Therapeutics Inc

Latest XLO News